ikulo wrote:This one is going to be a blockbuster. I'm sure they're going to price it accordingly.
DizzyDean wrote:BG12 appears to be the second generation of a prior compound whose brand name is fumaderm. Fumaderm is approved in Germany to treat psoriasis but from what I've read - isn't generally used as first line therapy. It doesn't sound like fumaderm is particularly expensive in Germany - but its not the same compound as BG12.
On the topic of "will neuros prescribe it", and "will insurers pay for it", I found this:
http://decisionresources.com/News-and-E ... sis-112811
In Australia, I think the real question will be "will it be subsidised by the Govt?"jay123 wrote:With the money drug companies will be throwing at doctors of course they will prescribe it.
Users browsing this forum: No registered users